PharmaEngine Statistics

Total Valuation

PharmaEngine has a market cap or net worth of TWD 12.90 billion. The enterprise value is 9.05 billion.

Market Cap	12.90B
Enterprise Value	9.05B

Important Dates

The last earnings date was Wednesday, April 30, 2025.

Earnings Date	Apr 30, 2025
Ex-Dividend Date	Aug 12, 2024

Share Statistics

PharmaEngine has 143.68 million shares outstanding. The number of shares has increased by 0.13% in one year.

Current Share Class	143.68M
Shares Outstanding	143.68M
Shares Change (YoY)	+0.13%
Shares Change (QoQ)	+0.45%
Owned by Insiders (%)	1.25%
Owned by Institutions (%)	5.96%
Float	93.43M

Valuation Ratios

The trailing PE ratio is 7.30 and the forward PE ratio is 28.64.

PE Ratio	7.30
Forward PE	28.64
PS Ratio	5.07
PB Ratio	2.34
P/TBV Ratio	2.35
P/FCF Ratio	5.92
P/OCF Ratio	5.92
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.35, with an EV/FCF ratio of 4.15.

EV / Earnings	5.11
EV / Sales	3.55
EV / EBITDA	4.35
EV / EBIT	4.36
EV / FCF	4.15

Financial Position

The company has a current ratio of 13.34, with a Debt / Equity ratio of 0.00.

Current Ratio	13.34
Quick Ratio	13.29
Debt / Equity	0.00
Debt / EBITDA	0.00
Debt / FCF	0.00
Interest Coverage	13,923.34

Financial Efficiency

Return on equity (ROE) is 37.50% and return on invested capital (ROIC) is 27.39%.

Return on Equity (ROE)	37.50%
Return on Assets (ROA)	25.89%
Return on Invested Capital (ROIC)	27.39%
Return on Capital Employed (ROCE)	37.66%
Revenue Per Employee	57.87M
Profits Per Employee	40.26M
Employee Count	44
Asset Turnover	0.51
Inventory Turnover	2.00

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -3.75% in the last 52 weeks. The beta is 0.30, so PharmaEngine's price volatility has been lower than the market average.

Beta (5Y)	0.30
52-Week Price Change	-3.75%
50-Day Moving Average	95.91
200-Day Moving Average	94.72
Relative Strength Index (RSI)	47.58
Average Volume (20 Days)	703,016

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PharmaEngine had revenue of TWD 2.55 billion and earned 1.77 billion in profits. Earnings per share was 12.30.

Revenue	2.55B
Gross Profit	2.50B
Operating Income	2.07B
Pretax Income	2.19B
Net Income	1.77B
EBITDA	2.08B
EBIT	2.07B
Earnings Per Share (EPS)	12.30

Full Income Statement

Balance Sheet

The company has 5.67 billion in cash and 6.97 million in debt, giving a net cash position of 5.66 billion or 39.40 per share.

Cash & Cash Equivalents	5.67B
Total Debt	6.97M
Net Cash	5.66B
Net Cash Per Share	39.40
Equity (Book Value)	5.50B
Book Value Per Share	38.19
Working Capital	5.49B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.18 billion and capital expenditures -502,000, giving a free cash flow of 2.18 billion.

Operating Cash Flow	2.18B
Capital Expenditures	-502,000
Free Cash Flow	2.18B
FCF Per Share	15.18

Full Cash Flow Statement

Margins

Gross margin is 98.07%, with operating and profit margins of 81.48% and 69.58%.

Gross Margin	98.07%
Operating Margin	81.48%
Pretax Margin	85.94%
Profit Margin	69.58%
EBITDA Margin	81.54%
EBIT Margin	81.48%
FCF Margin	85.64%

Dividends & Yields

This stock pays an annual dividend of 6.00, which amounts to a dividend yield of 6.62%.

Dividend Per Share	6.00
Dividend Yield	6.62%
Dividend Growth (YoY)	-25.00%
Years of Dividend Growth	n/a
Payout Ratio	12.16%
Buyback Yield	-0.13%
Shareholder Yield	6.49%
Earnings Yield	13.73%
FCF Yield	16.90%

Dividend Details

Stock Splits

The last stock split was on July 26, 2017. It was a forward split with a ratio of 1.1999616012.

Last Split Date	Jul 26, 2017
Split Type	Forward
Split Ratio	1.1999616012

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a